The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)
Open accessAbstract
Altered gene expression is a characteristic feature of many disease states such as tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation. Alterations in global gene expression are strongly impacted by post‐transcriptional gene regulation. The RNA binding protein (RBP) HuR (ELAVL1) is an established regulator of post‐transcriptional gene regulation and is overexpressed in most human cancers. In many cancerous settings, HuR is not only overexpressed, but it is “overactive” as denoted by increased subcellular localization within the cytoplasm. This dysregulation of HuR expression and cytoplasmic localization allows HuR to stabilize and increase the translation of various prosurvival messenger RNA (mRNAs) involved in the pathogenesis of numerous cancers and various diseases. Based on almost 20 years of work, HuR is now recognized as a therapeutic target. Herein, we will review the role HuR plays in the pathophysiology of different diseases and ongoing therapeutic strategies to target HuR. We will focus on three ongoing‐targeted strategies: (1) inhibiting HuR's translocation from the nucleus to the cytoplasm; (2) inhibiting the ability of HuR to bind target RNA; and (3) silencing HuR expression levels. In an oncologic setting, HuR has been demonstrated to be critical for a cancer cell's ability to survive a variety of cancer relevant stressors (including drugs and elements of the tumor microenvironment) and targeting this protein has been shown to sensitize cancer cells further to insult. We strongly believe that targeting HuR could be a powerful therapeutic target to treat different diseases, particularly cancer, in the near future. This article is categorized under: RNA in Disease and Development > RNA in Disease NRA Turnover and Surveillance > Regulation of RNA Stability Translation > Translation Regulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
AU-rich elements: characterization and importance in mRNA degradation
Chen, C.-Y. A., & Shyu, A.-B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89102-1 · Cited by 1,948
Transcriptome-wide Analysis of Regulatory Interactions of the RNA-Binding Protein HuR
Lebedeva, S., Jens, M., Theil, K., Schwanhäusser, B., Selbach, M., Landthaler, M., & Rajewsky, N. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.008 · Cited by 716
Srikantan, S. (2012) · Frontiers in Bioscience · doi:10.2741/3921 · Cited by 353
A conserved family of elav-like genes in vertebrates.
Good, P. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4557 · Cited by 319
Highly Selective Actions of HuR in Antagonizing AU-Rich Element-Mediated mRNA Destabilization
Chen, C.-Y. A., Xu, N., & Shyu, A.-B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7268-7278.2002 · Cited by 176
Izquierdo, J. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800017200 · Cited by 156
Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat
Amadio, M., Pascale, A., Cupri, S., Pignatello, R., Osera, C., DAgata, V., DAmico, A. G., Leggio, G. M., Ruozi, B., Govoni, S., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.042 · Cited by 113
Cited by
RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabbiano, F., Corsi, J., Gurrieri, E., Trevisan, C., Notarangelo, M., & D'Agostino, V. G. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12043 · Cited by 302
RNA-Targeted Therapies and High-Throughput Screening Methods
Zhu, S., Rooney, S., & Michlewski, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082996 · Cited by 41
Schultz, C. W., McCarthy, G. A., Nerwal, T., Nevler, A., DuHadaway, J. B., McCoy, M. D., Jiang, W., Brown, S. Z., Goetz, A., Jain, A., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0652 · Cited by 34
Self-citationPonzini, F. M., Schultz, C. W., Leiby, B. E., Cannaday, S., Yeo, T., Posey, J., Bowne, W. B., Yeo, C., Brody, J. R., Lavu, H., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073839 · Cited by 15
Self-citationChallenges in Therapeutically Targeting the RNA‐Recognition Motif
Schmeing, S., & Hart, P. '. (2024) · WIREs RNA · doi:10.1002/wrna.1877 · Cited by 11
Metadata
- Authors
- Schultz, C. W., Preet, R., Dhir, T., Dixon, D. A., & Brody, J. R.
- Venue
- WIREs RNA
- Publisher
- Wiley
- Published
- 2020-01-23
- Volume
- 11
- Issue
- 3
- Pages
- e1581-e1581
- ISSN
- 1757-7004 (ISSN-L)
- 1757-7012
- OpenAlex
- W3002398598
- Cited by
- 221
- References
- 8
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR). https://app.cochat.ai/papers/10.1002/wrna.1581
- The paper
- Schultz, C. W., Preet, R., Dhir, T., Dixon, D. A., & Brody, J. R. (2020). Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR). WIREs RNA. https://doi.org/10.1002/wrna.1581
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.